2 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Micardis: new trials by email Literature Review of Micardis trials Research Report on Micardis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial Lopinavir/Ritonavir 200 MG-50 MG Oral Tablet, Telmisartan 40Mg Oral Tablet, Atorvastatin 20 Mg Oral Tablet - COVID-19, COVID-19 Drug Treatment | Phase 2 / Phase 3 | Completed | ANRS, Emerging Infectious Diseases | 294 | 2020-11-27 | 2024-12-27 |
| Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients ACE Inhibition, Intensified Blood Pressure Control, Add-on Angiotensin Receptor Blockade - Children, Chronic Renal Failure | Phase 3 | Completed | Heidelberg University | 400 | 1998-01-01 | 2010-01-12 |
COVID-19 (1) · Cardiovascular Diseases (1) · Disease Progression (1) · Hypertension (1) · Hypertrophy, Left Ventricular (1) · Kidney Failure, Chronic (1)
ANRS, Emerging Infectious Diseases (1) · Heidelberg University (1)
Czechia (1) · Côte d’Ivoire (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Lithuania (1) · Poland (1) · Portugal (1) · Serbia (1) · Sweden (1) · Switzerland (1) · Turkey (Türkiye) (1)
Franz Schaefer, MD (1) · Otto Mehls, MD (1)
PMID 14630977, PMID 14744931, PMID 15253732, PMID 15647341, PMID 15772249, PMID 16093916, PMID 37119829, PMID 39443527